COMMUNIQUÉS West-GlobeNewswire

CRISPR Therapeutics to Present New Data on Allogeneic CRISPR-based CAR-T Program and Host Investor Reception at the 32nd Annual Society for Immunotherapy of Cancer Meeting

07/11/2017 - 14:00

ZUG, Switzerland and CAMBRIDGE, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP ), a genome editing company focused on creating transformative medicine for serious diseases, today announced [...]

OPKO Health Submits Premarket Approval Application with FDA for a Point-of-Care PSA Test with the Claros® 1 Platform

07/11/2017 - 14:00

MIAMI, Nov. 07, 2017 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK ) ("OPKO" or "the Company") announces the filing of a Premarket Approval (PMA) application with the U.S. Food and Drug Administration (FDA) for the [...]

G1 Therapeutics to Present at Stifel 2017 Healthcare Conference

07/11/2017 - 14:00

RESEARCH TRIANGLE PARK, N.C., Nov. 07, 2017 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (NASDAQ: GTHX ), a clinical-stage oncology company, announced today that Chief Executive Officer Mark Velleca, MD, PhD, will present [...]

Portola Pharmaceuticals Announces New APEX Study Sub-Analyses Data on Betrixaban to be Presented at the America Heart Association (AHA) Scientific Sessions 2017

07/11/2017 - 14:00

SOUTH SAN FRANCISCO, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals Inc. ® (Nasdaq: PTLA ) today announced that results of new sub-analyses of the APEX Study of betrixaban will be presented in oral [...]

Aptose To Release Third Quarter Ended September 30, 2017 Financial Results and Hold Conference Call on November 14, 2017

07/11/2017 - 14:00

SAN DIEGO and TORONTO, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Aptose) (NASDAQ: APTO ) (TSX: APS ), a clinical-stage company developing highly differentiated therapeutics targeting the underlying [...]

Spring Bank to Present at Piper Jaffray’s 29th Annual Healthcare Conference

07/11/2017 - 14:00

HOPKINTON, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH ), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, [...]

Five Prime Therapeutics to Host Conference Call on November 11th to Review Cabiralizumab Phase 1a/1b Data to be Presented in Late Breaking Oral Presentation at the Society for Immunotherapy of Cancer (SITC) 32nd Annual Meeting

07/11/2017 - 14:00

SOUTH SAN FRANCISCO, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (NASDAQ: FPRX ), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology [...]

DiaMedica Therapeutics Announces Publication of Positive Clinical Results for DM199 in the International Journal of Clinical Trials

07/11/2017 - 14:00

MINNEAPOLIS, Nov. 07, 2017 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (the “ Company ”) (TSX Venture:DMA) (OTCQB:DMCAF), a clinical stage biopharmaceutical company focused on improving the lives of patients with [...]

Krystal Biotech’s KB103 Granted Orphan Drug Designation by the FDA to Treat Patients With Dystrophic Epidermolysis Bullosa

07/11/2017 - 14:00

PITTSBURGH, Pa., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (Nasdaq: KRYS ), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from dermatological [...]

Jounce Therapeutics to Present Preclinical Data at the Society for Immunotherapy of Cancer (SITC) 32nd Annual Meeting

07/11/2017 - 14:00

CAMBRIDGE, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE ), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers [...]

Alimera Sciences' CEO Dan Myers to Present During Ophthalmology Innovation Summit at American Academy of Ophthalmology 2017

07/11/2017 - 13:30

ATLANTA, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ:ALIM) (Alimera), a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, today announced that Dan Myers, [...]

Selecta Biosciences Announces Third Quarter 2017 Financial Results and Provides Corporate Update

07/11/2017 - 13:30

WATERTOWN, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ:SELB), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies by avoiding unwanted [...]

Spark Therapeutics Reports Third Quarter 2017 Financial Results and Recent Business Progress

07/11/2017 - 13:30

PHILADELPHIA, Pa., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, announced today financial [...]

Strongbridge Biopharma plc to Present at the Stifel 2017 Healthcare Conference

07/11/2017 - 13:30

DUBLIN, Ireland and TREVOSE, Pa., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]

Zynerba Pharmaceuticals to Present at Upcoming Investor Conferences

07/11/2017 - 13:30

DEVON, Pa., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) a clinical-stage specialty pharmaceutical company dedicated to developing and commercializing innovative pharmaceutically- [...]

Repligen Extends Long Term Supply Agreement with Purolite for Protein A Ligands

07/11/2017 - 13:30

Waltham, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that is has extended a long-term supply agreement with Purolite Life Sciences for the manufacture of Protein A ligands [...]

Geron Announces November Investor Conference Presentation Webcasts

07/11/2017 - 13:30

MENLO PARK, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present at the following investor [...]

Conatus to Present at Stifel Healthcare Conference

07/11/2017 - 13:30

SAN DIEGO, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today announced its scheduled presentation to provide an overview of the company’s programs and outlook at the Stifel 2017 [...]

Spark Therapeutics and Pfizer Amend License Agreement for Investigational SPK-9001 in Hemophilia B

07/11/2017 - 13:15

Spark Therapeutics to receive up to an additional $25 million per terms of amendment